More US mass tort litigation is to be expected. This is what the predictions by Praedicat show. Today, opioid-related claims are up on the agenda with a potential bill of up to USD 864 billion. But there is likely more to come: from sugar to bisphenol A substitutes and a whole range of other chemicals and ingredients. Praedicat also shows that there is meanwhile a huge gap in coverage of insurable risks.
We will discuss the mechanics of US product liability litigation at our Casualty Day on 10 October in Dusseldorf. Find out more here.

/Passle/59994aefb00e801a0c1447be/SearchServiceImages/2026-09-08-20-03-54-781-6aa06a2a8307ddbad28442c6.jpg)
/Passle/59994aefb00e801a0c1447be/SearchServiceImages/2026-09-08-19-45-35-201-6aa065dfd27ce9f0cbaf0941.jpg)
/Passle/59994aefb00e801a0c1447be/SearchServiceImages/2026-09-08-18-38-20-225-6aa0561c0b54ee409a83dcae.jpg)